0.00Open0.01Pre Close0 Volume342 Open Interest89.00Strike Price0.00Turnover2444.61%IV7.45%PremiumMay 2, 2025Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.01Extrinsic Value100Contract SizeAmericanOptions Type0.0117Delta0.0122Gamma8284.00Leverage Ratio-61.5930Theta0.0000Rho96.84Eff Leverage0.0000Vega
Merck & Co Stock Discussion
For the revenue consensus estimate, analysts anticipate revenue around $15.48 billion, which would be a slight decrease of about 1.9% year-over-year.
Wall Street expects Merck to report EPS of approximately $2.16. This would r...
Landmark Trial: Merck's New PAH Drug Shows Stunning 76% Reduction in Life-Threatening Events
No comment yet